OKYO Pharma Ltd (NASDAQ:OKYO) said chairman Gabriele Cerrone, through Panetta Partners Ltd, bought 25,000 shares at $1.40 each, increasing his stake to 10.85 million shares, or 20.51% of the company.
Additionally, OKYO announced it will present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference on July 22, where CEO Robert Dempsey and Chief Medical Officer Flavio Mantelli will discuss the company's clinical programs.